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CHAPTER B
Summary and general discussion
The noradrenergic system of the brain plays a crucial rolc irr  rnany physiological
and pathological processes. In the present hesis the dual-probe nricrodialysis r.ncthod was
used to study the regulation of the noradrenaline rclcasc Íiorn thc LC ncurons. ln the Ílrst
parr of this thesis scvcral propeft ies of noradrenaline release and rnetabolisnr in thc LC
and one of i ts project ion areas the plefrontal corlcx (PFC). were studied. ln the second
parl the interaction bctween the LC and the dorsal raphe nucleus (DRN). one of the main
scrotonergic nr-rclei in the brain. was investigatcd. The f irst ctrapter highl ights the
anatomy and f irnct ional signif icance of noradrenergic systcm and sur-nrnariscs the rolc of
noradrenaline as neurotransrritter in thc brain.
The signi/icance antl motluluÍiort of extrut'ellulur lcvel.; tÍ norudrenulirte und DOPIC. in
the LC
The second chapter was addressed to thc rcgulat ion of thc rclease oÍ '
noradrenaline in the LC and PFC. To that cnd various reccptor spcciÍ ic compounrt nere
infused in the LC by rctrograde dialysis and the release of noradrenaline u'as recorded by
dual probc miclodialysis sirnultaneously in the LC and ipsi lateral PFC'. Application of a
calcium-Íiee Ringer's solut ion or tetrodotoxin ( l  t" tM) to the LC dccrcasccl noradrcnal ine
in the LC ïo 25oÁ of basal levels. indicating that extracel lular noradrenalinc samplcd in
this region is of neuronal origin and released by exocytosis.
The release of noradrenaline fiom the LC and PFC is regulated by
autoadrenoceptors. The role of q-adrenoceptors ir.r rcgulation of thc LC actir,ity has
received considerable attention in the l i terature. Infusion of the cr2-adrenoceptor agonist
clonidine (100 uM) in thc LC dccreased extracelhrlar noradrenaline in the LCI as u'el l  as
in the PFC tD 25% of basal levels. This l'inding suppofts the general vicw that the
actir.'ation of cr:-autoadrenoceptors uppresses the irnpulsc Í'low of noradlcncrgic cells.
lnf irsion of the a2r-adrcnoceptor antagonist BRL 4'+408 ( l  100 pM) in the LCI
strongly enhanccd thc rclease of noradrenaline in the LC (to about 700'fó of controls).
Infusion of 100 uM BRL 44408 st imulated the relcase of noradrcnal inc also in the
ipsi latcral PFC to about I  50% of controls. These rcsults suggcst that a:-adrenoceptors
inhibit  the f ir ing rate of LC ncurons and thc rclcase of noradrenaline in a tonic Í irshion.
Unlike u2-autoadrenoceptols the implication of t t l -adrcnoccptors in regulat ion of
the  LC is  no t  yc t  c lear .  In fus ion  o f  the  cL l -adrenoceptor  agon is t  c i razo l ine  (10-100 t tM)
via the microdialysis probe in the LC induccd a pronounccd incrcase (to about 450()í of '
controls) in noradrenaline levels in the LC. Horvever no effects were sccn in the
ipsi lateral PFC, which indicatcs that thc impulse Í low of noradrenergic cel ls r," 'as nol
affected during inftsion ofthc cxr-adrenoceptor agonist.  Interestingly. rvhen cirazol inc
(10 UM) was applied to project ion areas of the LC, namely the PFC or DRN. thc
compound also cnhanccd thc release of noradrenaline (to about 400(% of basal levcls).
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Although i t  is gcneral ly, accepted that c1-adrenoccptclrs play a nrinor role in ihe LC, oLrr
f indings indicate a signif icant function Íbr this receptors.
\ \ 'hcn the GABA,T antagonist bicucul l ine rvas applied ro the LC. noradrenaline
incrcirsed in the LC as well as in the PFC. This Í'inding suppofts litcrature provided
er''iclences that CAtsAelgic alÍerents exert a tonic inhibitory inÍ)uence on noladrenergic
cel ls in the LC.
Next u'e stut l ied thc role of the !HT1.1-serotonin receptor in the LC. During
infusion of the spccif ic 5-HTrr agonist f lesinoxan ( l  LrM) extracel lular levels of
noradrenalinc in thc LC decrcased nrarkedly (to 2-501, of basal levels). A sinri lar decreasc
of noradrenaline release was seen rvhcn Í'lesinoxan was inÍused in other brain areas such
as the PFC or DRN (C'hapter 6). which yroints to a general mechanisnt. As the effcct o1-
llesinoxan during inÍ'usion in the LC n'as not detectable in the ipsilateral PF-C. it is
concluded that !HTra receptors regulate the release of norirdrenaline via a local
rnechanisnr without altcr ing the clectr ical act ivi ty of the noradrencrgic el ls.
Although our study has characterised the propeft ies of t l ie noradrenaline relcase in
the LC. the origin and role of noradrenaline within the ccl l  body area of the LC is not
ful ly clari f icd at thc present t ime. The question remains whether dendli tes contr ibute to
the release of noradrenaline in the LCl. One of the propcrt ies of denclr i t ic release is i ts
impulse l lor ' , 'dr iren nature. I f  we define clendrit ic release by impr-r lse f lou,dependency. i t
is erident that in thc i .rbove cxperirncnts thc clrug-induced moduiat ion of noradrenalinc
rclease in the LC does not Íulf i l  this cr i ter ion. Thc release of noradrenaline in the LC is
thereÍbrc rrtost casi ly intcrpreted bv release derived Í j 'om col laterals. I Iowel,er the f inding
frorn Lee and corvorkers that collateral's in the LC do not possess o.l-adrenoÍeceptors
(Lee et al. ,  1998a. see Chapter I) .  is in Íavour of a dcndrit ic origin of noradrcnal ine. I t  is
emphasiscd that i f  dendrit ic release also irnpl ies impulse Í1ow independcnt release
(modiÍ ied by auto- ancl hcterorecepbrs l ikc on uervc tenninals). then this type of relcase
can not bc discrjrninated froni classical nen'c terminal release by the prcsent approach.
In chapter three the possible role of or-autoadrenoceptol 'on LC ncurons u'as
Íurlher investigated. Prazosin was infused in thc LC and noradrcnal ine release rvas
detenrrinecl in the LC' as well  as the ipsi latelal PFC. During application of prazosin
extracellular noradrcnaline in the LC decreased rvhcreas in the PFC noradrenaline
showccl a tendencl' to decrease. Next thc interaction betwcen the cfÍècts of prazosin and
o.:-adrenoceptors was studicd. Infusion of idazoxan (100 pMl in the LCI increased
noradrenaline in dialvsates of the LC ancl PFC'. When idazoxan rvas coinfuse.d together
r.vith thc crl-adrenoceptor ar-rtagonist prazosin the efï'cct of thc cr2-antagonist rvas strongly
attenuated both in the LC as rvel l  as in thc PFC. The decrease in the PFC indicate that
prazosin is ablc to decrcase the irnpulse t low activi ty ofthe LC neurons.
The experiments with idazoxanancl prazosin'ur,ere confirmed by using the specif ic
o,tA-antagonist 8RL44.108. Therelbre our data strongly suppoÍt an autoinhibitory role of
cxt -adrenoceptors on LC ncurons. I t  is suggested that cLl-autoadreccptors arc able to
rnodify the relcase of noradrenalinc l iom nerve temrinals ancl irnpulsc Í1ow activi ty of LC
ncurons. ln this lcgard i t  is irnporlant to notc that recently mRNA for cr1 -adrcnoceptors
was described in LC cel ls (Osborne et al. ,  2002. see Chapter l) .  Apparently u1-
adrcnoceptor and c2-ai lrenoccptor lrave opposing rolcs r.r 'hen acting as aulorcceptors.
This is substantiated by t l ie Í indings that the various agonists and antagonists had
opposite eÍ ' Íccts on thc releasc of noradrcrral ine: cxl-agonists and u1-anta-qonists increased
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noradrcnal inc release u,hi le ctt-antagonists irncl cxl-agonists caused a dccrease of
noraclrcnal inc whcn applied local ly to LC neurons.
Aparr fiom autoreceptors that directly act on rclcase mechanisms and impulsc
flow activity, neuronal feedback loops have been hypothesised to control the irctivity of
LC noradrenaline neurons. Such a neuronal feedback loop is supposed to couple the
impact of noradrenaline relcascd Íiom nene tenninal back to thc LC region. In chapter
four we have attempted to visual izc the neuronal feed back loop by combining systenric
and local ( in the LC) administrat ion of the noradrenergic reuptake inhibitor desipranrine.
A sYstenl ic administrat ion of desiplarr i ine r '"as appl ied to nrinric the aroused state t l l -
noradrcncrgic systen.r ancl as a result of this to t ir l l l ,act ivate the Íèedback loop in thc
tenninal regions. To prevent a direct act ion of systemical ly administered dcsiprrmine on
the reuptakc sites within the LC we first blocked these uptake sites by local infusion of
desipramine in the LC. Local infusion of desipramine (10 prM) in the LC induccd a large
incrcasc- of the noradrenaline levels in the LC to about 500%. After a new baseline was
establ ished desipramine was administered systemical ly (20 mg/kg). Under these
condit ions systemic administrat ion of desipramine produced a decrease in the release of
noradlenal ine in the LC. This cleclease is in our view evidence for an inhibitory neuronal
loop that origrnates in thc ternrinal areas and Íèecls back to the LC.
Next we tr ied to f incl receptors that might rnediate this Íèedback inhibit ion.
Systerr ic inject ion of thc ar-adrenoceptor antagonist prazosin (3 rng/kg) or the B-
adrenoceptor antagonist propranolol (3 mg/kg) did not attenuate the effect of fèedback
inhibit ion tr iggered by dcsipramine. Inject ion ofthe crz-adrenoceptor antagonist idazoxan
given plior injection of desipramine prevented thc suppression of the noradrenalinc
relcase in the LC. while the eÍ-Íect on noradrenaline output in the PFC was potenl iated.
This leads to the conclusion that posts,vnaptic o.r-adrenoceptors are involved in thc eÍÈct
of the neuronal feedback inhibit ion of the LCI nrrradrcncrgic system.
It has been suggested in the l i teraturc that in the LC the doparnine nretabol i tc 3,4
dihydloxyphenylacetic acicl (  DOPAC) should be considered as a nretabol i te of
noraclrcnal ine. In the f i f th chapter we investigated thc relat ion between ertracel lular
DOPAC and noradrcnaline in the LC. To that end DOPAC and noradrenaline were
simullaneously measurcd in the LC. Infusion of the u,1-adrenoceptor agonist clonidine
(100 pM). the GABA'r rcccptol antagonist bicucul l ine (50 pM) or thc nruscarinic
receplor agonist carbachol (100 pM) in thc LC induced paral lel changcs in the
crtraccl lular '  levels of DOPA('and noradrcnal ine. ,{  paral lcl  increase wa.s also seen al ler '
e\posurc ofa rat to l5 nrin ofnovelty. In contrarv. aÍter infusions ofthe crr-adreuoceptor
agon is tc i razo l ine(100 t " t l \4 ) . thes : , r -adrenoceptoran tagon is tBRL44408(100 pM)and
the 5-HTrr rcceptor agonist f lesinoxan ( l  pM) in the LC. dramatic changes were
observed in extracel lular noradrcnal inc bi l  the DOPAC levels remained vitual ly
consÍaÍrt.
These results indicate t lrat,  during various phvsiological and phanracological
condit ions. the changes in DOPAC levels in the LC rcpresent diÍ lèrent processes.
DOPAC is plobablv derivcd Íionr thc trvo diÍÍèrent pools: one pool originates Íiorl basal
nictabol ic act ivi ty and iurother related to the electr ical act ivi ty of the LC. Stintulat ion of
LC ncurons wil l  cause phosphorylat ion of tyrosine hydroxylasc. which i i ' i l l  lead to an
increased production of DOPAC. Extlacel lular noradrenaline also seems to rcÍ lcct a
surnntation of trvo processes: the noradrcnal inc rclcase that depends on L( '  electr ical
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activi ty and rel i ' i rse that is rcgulated by a local presynaptic l impulse-f low indcpcndent)
nrcclranism.
The inÍeracíion ltetu'een LC nttrudrenaline neuron.; und DR scroÍonin ileut'ons
The interaction between the LC ancl DRN was studied using dual probe
nriclodialysis and i t  is descl ibed in the sixth chapter. Extraccl lular levels of
noradrenaline or serotonin wcre simultaneously recorded in both nuclei during
application by retrogradc microdialysis - o1'receptor spccif ic compounds to the LC or
DRN. The mechanism underlying mutual regulat ion of the activi ty of these two structures
was investigated by suppressing or st imulat ing the activi ty of these two nuclei.
According ïo l i terature data the DRN exerts a tonic inhibitory inf lucnce on the
LC. This conclusion was rnainly based on the lact that atter lesion of the DRN the
activi ty of the LC was elevated. The present study Íbund no evidcnce Íbr such inhibitory
influence during resting conditions. The activity of the DRN was suppresscd by local
infusion of the tHTln-receptor agonist f lesinoxan ( I  pM). During inÍusion of f lesinoxan.
t lre lelease of serolonin decreased in thc DRN and LC to 459ó and ó5% of controls.
respectivelv. Notwithstancl ing the decreascd serotonin input. the release of noradrenaiine
in the LC renraincd unchanged suggesting that thc activi ty of thc LC was not altercd.
Activation of the DRN was not carried out in this study because the stinrulation of the
DRN induced general behavioural act ivat ion and under such condit ions the specif ic
DRN-LC connection could not bc- establ ished.
Next rve investigatccl whether thc LC is able tcl int'luence the DRN. The
suppression of the LCI activi ty by local inf irsion of clonidine (100 pM) dccreased the
release of noradrenaline to 20r/o of controls in the LC and 30% of controls in the DRN.
During thesc condit ions the rclease of serotonin Í iorn the DRN decreased to 80% olbasal
ler,els. This Írnding suppofts the idea that the LC cxerts a tonjc excitatory inf luence on
the  DRN.  Erc i ta t ion  o f ' the  LC by  in fus ion  o f  the  rnuscar in ic  agon is tcarbacho l  (100 pMl
led to an increasc in the releasc of noradrenalinc to 240?o and2200Á of controls in the LC
and DRN, respectively. Interestingly, despite this pronounced st imulat ion of
noradrenaline release no change in the rclease of serotonin was noticed in the DRN. l t
dernonstrates that the excitatory inÍ luence of the LC on thc DRN is already maximal
under the resting sondit ions.
To investigate in morc detai l  the regulat ion of the serotonin release in thc DRN b1'
noradrenergic affercnts, dual probe microdialysrs of scrotonergic neurons in the DRN and
its projection area PFC was carried out. Thc results are described in the seventh chapter
ofthis thesis. ln this approach thc release ofsclotonin in the PFC was considered to be an
indicator of the activi ty of the serotonergic ncurons in the DRN. Alplral-and o.2-
adrenoceptor agonists and antagonists werc locally inir"rsccl in the DRN via rctrograde
microdialysis. l-ocal infusion of thc cx,r -adrenoceptor antagonist prazosin (10 ptM) in the
DRN dccreased the serotonin release in both the DRN and right PFC (to 45oÁ and 70% of
thc- basal levels. rcspectively). Apparently the DRN is permanently uncler the tonic
cxcitatory control by the noraclrenergic aÍ-Èr'ents fronr thc LC. acting via (rr-
adrcnoceptors.
Interestingly, when thc cxr-adrenoceptor agonist cirazol ine ( 100 pM) rvas
administered in the DRN. the relcase of serotonin was increased in the DRN to 200% of
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basal levels; however no ef-Íects wcrc sccn in the right PFC. These data dcnronstratc that
o,r-adrenoceptors in the DRN arc maximally act ivated during resting condit ions. This
result is in good accordance with the f indings dcscribed in cl iapter six.
Next thc impact ol the cr:-adrenoccptors on the release of serotonin and the
activi t l , 'of the DRN was exarninecl.  lnÍusion of the o,2-adrenoceptor agonist clonidinc in
thc DRN 1100 ptM) signif icantlv clccreased the level of serotonin in thc DRN as well  as in
the PFC to about 70')Á ol the basal le' ,cls. These results are best explained in accorclancc
rvith Í indings ofSvensson et al.  (1975. see Chapter 7). They suggest that the inhibitory
action of clonidine on DRN octivi ty is an indirect one. nanrely a rcsult  of st irnulatron of
c1:-autoadrcnoceptors on the teminals of thc noradrenergic aÍÍerents in the DRN.
Consequently the actir , i ty of the DRN wil l  decrease due to insulïcient st imulat ion of c1-
adrenoccptors by repressed noradrenergic afï'crents.
InÍusion of the q:a-adrenoceptor antagonist BRL 44.108 in the DRN (100 ptM)
causecl an increase of serotonrn release in thc DRN Io 2l0u,u of the basal levels. but no
charrgcs were seen in the extraccl lular levels of serotorr in in thc ipsi lateral PFC.
Consiclering the hypothesis of Si 'ensson and col leagues. one can expl icate thc increase o1'
serotoÍr ir1 afïcr BRL 4,14()8 intusion in the DRN as a result of st imulat ion of o1 -
adlenoccptors by enhanced levcls oÍ 'noradrenaline. l lowevcr this is an unl ikely
explanation as in our previous expcrimcnts (described in chapter six). in which the ler. 'els
of noradrcnal ine in the DRN *,cre cnhanced by st imulat ion of the LC with carbachol, the
extracel lular concentrat ion of serotonin was not changecl. I t  supports the idea that
inhibitory s,lA-adrenoceptors rnight be located not only on noradrcnergic tenninals within
the DRN but on serotonergic cl ls as rvel l .
In surnnrary. the effect oÍ- noradrencrgic project ions on serotonergic ncurons in thc
DRN is explained by a balance'bctrr,een st imulatory eÍ ' tccts of cIr-adrenoceptors and
inhibitorl ,  cttccts of cx. l-adrenocell tors. Thc noradrenergic act ivat ion of thc DRN appears
to bc a)ready nraximal during lcst ing condit ions.
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